千金药业(600479) - 2015 Q1 - 季度财报

Financial Performance - Operating revenue for the current period was CNY 447,621,391.10, an increase of 8.55% year-on-year[8]. - Net profit attributable to shareholders of the listed company was CNY 15,795,673.41, a decrease of 3.85% compared to the same period last year[8]. - Basic earnings per share increased by 19.27% to CNY 0.0650[8]. - The company reported a 626.59% increase in investment income compared to the same period last year, mainly from the disposal of financial assets[18]. - The profit attributable to the parent company's shareholders was CNY 19,825,461.61, up 19.5% from CNY 16,604,887.26 in the previous year[35]. - Basic and diluted earnings per share for Q1 2015 were both CNY 0.0650, compared to CNY 0.0545 in Q1 2014[35]. Cash Flow - Cash flow from operating activities generated a net amount of CNY 41,917,677.61, compared to a negative cash flow of CNY -25,178,538.49 in the same period last year[8]. - The net cash flow from operating activities increased by 67.10 million yuan compared to the same period last year, primarily due to higher cash receipts from sales[20]. - The net cash flow from investing activities increased by 65.13 million yuan compared to the same period last year, mainly due to the recovery of financial assets and reduced payments for construction[20]. - The net cash flow from financing activities decreased by 145.50% compared to the same period last year, primarily due to a reduction in borrowed funds[21]. - The net cash flow from operating activities for Q1 2015 was ¥41,917,677.61, a significant improvement compared to a net outflow of ¥25,178,538.49 in the same period last year, representing a turnaround of over 266%[38]. - The total cash inflow from operating activities was ¥260,601,410.22, while cash outflow was ¥234,147,113.76, resulting in a net cash flow of ¥26,454,296.46, down 60.4% from ¥66,944,320.96 in Q1 2014[40]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,228,472,882.04, a decrease of 0.02% compared to the end of the previous year[8]. - Total current assets decreased slightly to CNY 1,431,794,707.63 from CNY 1,443,551,798.26, a decline of approximately 0.8%[26]. - Total liabilities decreased to CNY 826,964,257.47 from CNY 843,200,979.39, a reduction of about 1.9%[28]. - Total equity increased to CNY 1,401,508,624.57 from CNY 1,385,728,142.19, reflecting a growth of approximately 1.1%[28]. - Non-current assets totaled CNY 796,678,174.41, up from CNY 785,377,323.32, an increase of approximately 1.6%[27]. Shareholder Information - The total number of shareholders at the end of the reporting period was 16,333[12]. - The largest shareholder, Zhuzhou State-owned Assets Investment Holding Group Co., Ltd., held 20.21% of the shares[12]. - The company plans to issue 43,177,893 shares to raise a total of 500 million yuan, with the issuance price set at 11.58 yuan per share[22]. Changes in Receivables and Inventory - Accounts receivable increased by 42.89% compared to the beginning of the year, mainly due to changes in collection policies[16]. - Other receivables grew by 140.78% compared to the beginning of the year, attributed to increased petty cash and prepaid rent by subsidiaries[16]. - Inventory increased to CNY 268,582,815.78 from CNY 243,208,150.70, an increase of about 10.5%[26]. - Accounts receivable decreased to CNY 138,268,780.06 from CNY 96,763,350.93, an increase of approximately 42.8%[26]. - Other receivables increased significantly to CNY 110,960,197.16 from CNY 46,083,960.22, a growth of about 140.5%[26]. Construction and Borrowings - Construction in progress rose by 140.67% compared to the beginning of the year, driven by increased project investments by subsidiaries[16]. - Short-term borrowings decreased by 37.70% compared to the beginning of the year, mainly due to repayments by a subsidiary[16]. - Short-term borrowings decreased to CNY 38,000,000.00 from CNY 61,000,000.00, a decline of approximately 37.7%[27].